News from invo bioscience, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 27, 2021, 09:00 ET INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), ...

Jan 15, 2021, 08:30 ET INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), ...

Jan 07, 2021, 09:00 ET INVO Bioscience Management Letter to Shareholders

INVO Bioscience, Inc. (NASDAQ: INVO) ("Company") ('INVO"), a medical device company focused on commercializing the world's only in vivo Intravaginal...

Nov 25, 2020, 09:00 ET INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia

INVO Bioscience, Inc. (Nasdaq: INVO) (the "Company") developers of INVOcell®, the world's only in vivo Intravaginal Culture System, entered into an...

Nov 18, 2020, 09:00 ET INVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility Industry

INVO Bioscience, Inc. (Nasdaq: INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced the formation of...

Nov 16, 2020, 16:20 ET INVO Bioscience Reports Third Quarter 2020 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and ...

Nov 12, 2020, 21:40 ET INVO Bioscience Announces Pricing of Follow-on Public Offering and Listing on the NASDAQ Capital Market

INVO Bioscience, Inc. (OTCQB: INVOD) (Nasdaq: INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced...

Sep 30, 2020, 09:15 ET INVO Bioscience Establishes Joint Venture to Operate Dedicated INVOcell Fertility Clinics in Mexico

INVO Bioscience, Inc. (OTCQB: INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, announced today it has teamed up...

Sep 16, 2020, 09:00 ET INVO Bioscience Announces Appointment of Barbara Ryan and Matthew Szot to the Board of Directors

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

Aug 13, 2020, 16:15 ET INVO Bioscience Reports Second Quarter 2020 Financial Results

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

Aug 06, 2020, 15:00 ET INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

INVO Bioscience, Inc. (OTCQB: INVO), ("the Company", "INVO") a medical device company focused on creating alternative treatments for patients...

Jul 16, 2020, 09:00 ET INVO Bioscience Receives Registration Approval for INVOcell in Turkey

INVO Bioscience, Inc. (OTCQB: INVO), ("the Company", "INVO") a medical device company focused on creating alternative treatments for patients...

Jul 02, 2020, 09:00 ET America Institute for Reproductive Medicine of Birmingham Alabama ("AIRM") Spotlights its Success in the Use of INVOcell

INVO Bioscience, Inc. (OTCQB: INVO), ("the Company", "INVO") a medical device company focused on creating alternative treatments for patients...

Jun 29, 2020, 09:00 ET INVO Bioscience Announces Closing of Financing

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

Jun 23, 2020, 08:00 ET INVO Bioscience Now Trading Under "INVO" Ticker Symbol On Tuesday, June 23, 2020

INVO Bioscience, Inc. (OTCQB: INVO), ("the Company") a medical device company focused on creating alternative treatments for patients diagnosed with...

Jun 19, 2020, 09:00 ET A Vista Partners Interview with Steve Shum CEO of INVO Bioscience Regarding Increasing Access to Care for Fertility Treatment

Today, Steve Shum, Chief Executive Officer of INVO Bioscience, Inc. (OTCQB: INVO) (OTCQB: INVOD), a medical device company focused on creating...

May 22, 2020, 16:01 ET INVO Bioscience Announces 1-for-20 Reverse Stock Split

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

May 15, 2020, 17:35 ET INVO Bioscience Reports First Quarter 2020 Financial Results

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

Apr 02, 2020, 09:00 ET INVO Bioscience Appoints Christopher Myer as VP Business Development - Americas

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today ...

Mar 30, 2020, 16:15 ET INVO Bioscience Reports 2019 Financial Results

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

Mar 16, 2020, 08:00 ET INVO Bioscience Changes Trading Symbol to "INVO" Effective March 16, 2020

INVO Bioscience, Inc. (OTCQB: INVO) ("INVO"), a medical device company focused on creating alternative treatments for patients diagnosed with...

Mar 11, 2020, 09:00 ET INVO Bioscience Appoints Yve Lyppens as Director Business Development Asia Pacific

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced ...

Feb 13, 2020, 09:00 ET INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced ...

Feb 05, 2020, 09:00 ET INVO Bioscience Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell Labeling

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced ...

Jan 21, 2020, 09:00 ET INVO Bioscience to Attend the 45th Edition of Arab Health Congress on January 27-30, 2020

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today ...